ArticleLung2022

Nationwide Real-Life Safety and Treatment Exposure Data on Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III, Locally Advanced, Non-small Cell Lung Cancer: Analysis of Patients Enrolled in the French Early Access Program.

Virginie Avrillon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.